The impact of HPV vaccines and screening tests on cervical cancer prevention: A National Cancer Institute Science Writers' Seminar
- Posted: September 21, 2010
Please join us for a science writers' seminar to discuss new research findings and future directions in HPV-related cancer research. Among the topics discussed will be the natural history of HPV and related cancers, advances in screening techniques and tools, the role of vaccines and microbicides in prevention, both nationally and internationally, and future research directions. The seminar will allow ample time for Q&A and interaction during the talks.
Mark Schiffman, M.D., Senior Investigator, Clinical Genetics Branch, NCI Division of Cancer Epidemiology and Genetics (DCEG): HPV and Cancer: Global Impact and Natural History of HPV and HPV-related Cancers
Diane Solomon, M.D., Acting Chief, Breast and Gynecologic Cancer Research Group, NCI Division of Cancer Prevention: The Evolution of Cervical Cancer Screening from Pap to HPV Testing
Allan Hildesheim, Ph.D., Chief, Infections and Immunoepidemiology Branch, DCEG: Efficacy of HPV Preventive Vaccines; Studies in Costa Rica and Beyond
John Schiller, Ph.D., Head, Neoplastic Disease Section, NCI Center for Cancer Research: Microbicides: Future Directions for Cancer Prevention
Tuesday, October 19, 2010: 9:00 a.m. – 11:30 a.m. (EDT)
National Institutes of Health
For reporters, please register for the seminar by contacting the NCI Office of Media Relations at (301) 496-6641 or email@example.com. Space is limited.
# # #